SCHEMBL7989310

SCHEMBL7989310

Cc1ccc(-c2cc(C)[nH]c2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.59
PTGS1 P23219 4/20 0.59
CA2 P00918 6/20 0.55
CA12 O43570 5/20 0.55
CA9 Q16790 5/20 0.55
CA1 P00915 5/20 0.55
CA3 P07451 1/20 0.55
CA6 P23280 1/20 0.55
CA5A P35218 1/20 0.55
CA7 P43166 1/20 0.55
CA5B Q9Y2D0 1/20 0.55
CHRNA7 P36544 2/20 0.50
GCGR P47871 1/20 0.46
MAPK14 Q16539 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5311606 0.90 CA2 (0.54) PTGS2PTGS1CA2CA12CA9
SCHEMBL7989315 0.86 PTGS2 (0.59) PTGS2PTGS1GCGRMAPK14
SCHEMBL7986415 0.86 CA2 (0.50) PTGS2PTGS1CA2CA12CA9
SCHEMBL7985400 0.86 PTGS1 (0.55) PTGS2PTGS1CA2CA12CA9
SCHEMBL7986247 0.79 PTGS2 (0.45) PTGS2PTGS1CA2CA12CA9
Dimethylamine SCHEMBL7983206 0.78 PTGS2 (0.54) PTGS2PTGS1CA2CA12CA9
SCHEMBL7983203 0.78 PTGS2 (0.63) PTGS2PTGS1CHRNA7
SCHEMBL7983135 0.78 PTGS2 (0.57) PTGS2GCGRMAPK14
SCHEMBL12692373 0.76 CA12 (0.86) PTGS2PTGS1CA2CA12CA9
SCHEMBL6725526 0.75 CA12 (0.73) PTGS2PTGS1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294568-B1 ANTIINFLAMMATORY AGENTS AND ANTITUMOR AGENTS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENTS AND COX2 ENZYME INHIBITORS NISSIN FOOD PRODUCTS CO., LTD. (JP) 2001-09-25 US disclosed
EP-1048649-A1 5-ARYLPYRROLE DERIVATIVES NISSIN FOOD PRODUCTS CO., LTD. (JP) 2000-11-02 EP disclosed